L

Lite Strategy Inc.
D

LITS

1.21000
USD
-0.01
(-0.82%)
مفتوح الان
حجم التداول
1,872
الربح لكل سهم
-15
العائد الربحي
-
P/E
-1
حجم السوق
43,998,019
المقالات

العنوان: Lite Strategy Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily,selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.